Overview

Study of the Safety of Intravenous Artesunate

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety, tolerability, and pharmacokinetics of a multiple dose of the antimalarial drug artesunate.
Phase:
Phase 1
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command
Collaborator:
Walter Reed Army Institute of Research (WRAIR)
Treatments:
Artemisinins
Artesunate
Mannitol